The CDC and FDA both called Tuesday for an immediate pause in the use of the Johnson & Johnson vaccine following reports of six women developing a rare blood clotting disorder after receiving the shot. Officials emphasized, however, that they were acting out of an abundance of caution. Dr. Nahid Bhadelia, medical director of the Special Pathogens Unit at Boston Medical Center, joined Jim Braude to discuss.